Novo Nordisk: 'on track' to meet long-term financial targets
(CercleFinance.com) - At its Capital Markets Day on Wednesday, Danish drugmaker Novo Nordisk said it expects to meet its long-term financial targets.
The world's biggest insulin producer said that it is on track to meet its current goals, including average operating profit growth of 5%, cash-to-earnings of 85% (a three-year average) and operating profit after tax over net operating assets of 80%.
The shares, however, are currently down about 1.5% on Cophenagen's Nasdaq Nordic market.
Copyright (c) 2019 CercleFinance.com. All rights reserved.
The world's biggest insulin producer said that it is on track to meet its current goals, including average operating profit growth of 5%, cash-to-earnings of 85% (a three-year average) and operating profit after tax over net operating assets of 80%.
The shares, however, are currently down about 1.5% on Cophenagen's Nasdaq Nordic market.
Copyright (c) 2019 CercleFinance.com. All rights reserved.